Malignancies occurring during therapy with tyrosine kinase inhibitors (TKIs) for chronic myeloid leukemia (CML) and other hematologic malignancies

Success of tyrosine kinase inhibitors (TKIs) in chronic myeloid leukemia (CML) has given patients hope for a long disease-free-survival. A longer survival raises the question of late effects, including development of another malignancy. Records of 1445 patients with CML/myeloproliferative neoplasm o...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Verma, Dushyant, Kantarjian, Hagop, Strom, Sara S., Rios, Mary Beth, Jabbour, Elias, Quintas-Cardama, Alfonso, Verstovsek, Srdan, Ravandi, Farhad, O'Brien, Susan, Cortes, Jorge
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2011
Assuntos:
Clinical Trials and Observations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3291487/
https://ncbi.nlm.nih.gov/pubmed/21846902
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2011-06-362889
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados